GAIA Q1 2026 Earnings Loss Narrowly Misses Estimates Shares Rise on Strategic Progress OPXS Q1 2026 Earnings Positive EPS of 003 Reported Amid Limited Disclosure VLYPP Q1 2026 Earnings Preferred Dividend Coverage Solid as EPS Beats Estimates IZEA Q4 2025 Earnings EPS Misses Estimates as Stock Rises on Potential Turnaround LGL Q1 2026 Earnings Sharp EPS Miss Amidst Minimal Revenue Disclosure SEE Q4 2025 Earnings EPS Beats Estimates by 428 as Operational Efficiency Drives Results Momentus Inc Q1 2026 Earnings Continuing Cost Control Amidst PreRevenue Phase uniQure NV QURE Q1 2026 Earnings Narrower Loss Beats Estimates Shares Edge Lower GLPG Q1 2026 Earnings Large EPS Beat on Lower Costs Stock Unchanged IN8bio Inc INAB Q1 2026 Earnings EPS Surprise of 63 Highlights Cost Discipline in PreRevenue Biotech GLPI Q1 2026 Earnings Modest EPS Miss Highlights Operational Stability Stock Edges Higher Bicara Therapeutics BCAX Q1 2026 Earnings ClinicalStage Biotech Reports WiderthanExpected Loss Shares Rise